Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …

Medicines have made an appreciable contribution to improving health. However, even high-
income countries are struggling to fund new premium-priced medicines. This will grow …

Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …

Objectives Society is confronted with the rapid emergence of innovation in science and
technology. To manage this, horizon scanning is being adopted globally to identify, assess …

Objectives: This article presents an overview of the practical methods and tools to support
transnational Health Technology Assessment (HTA) that were developed and pilot tested by …

Objective: To provide an overview of health services research related to health technology
assessment (HTA) and to identify research priorities from a European perspective. Methods …

Most European countries are formally building HTA into policy and reimbursement
processes. The development of HTA in Europe has been a combination of scientific, political …

Background: In the recent years, using health technologies to diagnose and treat diseases
has had a considerable and accelerated growth. The proper use of these technologies may …

Background: Organizational aspect is rarely considered in healthcare. However, it is
gradually seen as one of the key aspects of the decision-making process as well as clinical …

Objectives: Health systems frequently make decisions regarding acquisition and use of new
technologies. It is desirable to base these decisions on clinical evidence, but often these …